DOJ seeks 4-month delay, again, in generic price-fixing class actions

The US Department of Justice asked a Philadelphia federal judge to delay by another four months class actions accusing major pharmaceutical companies — including Mylan and Teva — of fixing prices...

Already a subscriber? Click here to view full article